NFKB1 and cancer: Important pathways that are involved in cancer development, and therefore also novel therapeutic targets, are nuclear factor-kappa B (NF-κB), mitogen activated protein kinase pathway (MAPK), Akt, Wnt, Notch, p53, and others.